Nucleic acid detection technology is the most direct and essential pathogenic evidence, which is better than other clinical interpretations of clinical manifestations, clinical signs, and CT detection. The RT-PCR diagnosis is simple and fast, can detect a large number of samples, and is low in cost. It is especially suitable for the large-scale epidemic of new coronary pneumonia. The accuracy of RT-PCR results depends on the quality of primers and probes. As the world's leading supplier of genes, proteins, and antibodies, Creative Biolabs can provide customers with reliable and high-quality SARS-CoV-2 (2019-nCoV) primers and probes. Our products have undergone strict quality control and verification and can be applied to the development of test kits and related research.